A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
NCT05013424
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
92
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
Formulation A: OnabotulinumtoxinA
DRUG:
Formulation B: OnabotulinumtoxinA
DRUG:
Formulation C: OnabotulinumtoxinA
Sponsor
Allergan